The gene ubiD (UniProt Q88CG8; ordered locus PP_5213) of Pseudomonas putida strain KT2440 encodes 3-octaprenyl-4-hydroxybenzoate carboxy-lyase (EC 4.1.1.98), also called polyprenyl p-hydroxybenzoate decarboxylase. This is a prenylated-FMN (prFMN)-dependent, UbiD-family enzyme that catalyzes the non-oxidative decarboxylation of 3-polyprenyl-4-hydroxybenzoate to 2-polyprenylphenol plus CO₂ (RHEA:41680), a committed step in the biosynthesis of ubiquinone (coenzyme Q). The gene symbol, protein description, UbiD-family domain architecture, and single-copy status in the KT2440 genome are all fully consistent with the UniProt-provided identity; there is no ambiguity in the assignment. This report describes the enzyme's function with high confidence, drawing on direct biochemical characterization of orthologs in Escherichia coli and Pseudomonas aeruginosa together with UniProt curation of Q88CG8 itself.
The enzyme is catalytically inert as a bare apoprotein. Its activity strictly depends on a remarkable modified flavin cofactor, prenylated FMN (prFMN), which bears a fourth non-aromatic ring formed by linking a dimethylallyl moiety to the FMN N5 and C6 atoms. prFMN is synthesized by the partner flavin prenyltransferase UbiX; P. putida KT2440 encodes a cognate UbiX (Q88QE6), so the genome contains a complete, functional UbiX–UbiD prFMN-dependent decarboxylation module. Catalysis proceeds through a chemically unusual, reversible 1,3-dipolar cycloaddition between the substrate and the azomethine-ylide form of oxidized prFMN — the first known enzymatic example of this cycloaddition chemistry. UbiD is a homohexamer, binding one prFMN per subunit, with an active-site proton donor and a conserved divalent metal (annotated as Mn/Mg) adjacent to the catalytic cleft.
Functionally, UbiD acts on the cytoplasmic side of the inner (cell) membrane as a peripheral membrane protein, and more precisely operates as a component of a soluble cytoplasmic "Ubi metabolon" — a ~1-MDa multienzyme complex that carries out the terminal reactions of ubiquinone biosynthesis in the cytosol. Because Pseudomonas uses ubiquinone-9 (Q-9) as its respiratory quinone, the physiological substrate in P. putida carries a C45 nonaprenyl (9-isoprene) tail rather than the octaprenyl chain in the E. coli-derived enzyme name; that is, the reaction in this organism is the decarboxylation of 3-nonaprenyl-4-hydroxybenzoate to 2-nonaprenylphenol.
UbiD (Q88CG8 / PP_5213) catalyzes the non-oxidative decarboxylation of 3-polyprenyl-4-hydroxybenzoate to 2-polyprenylphenol, a committed and essential step in the bacterial ubiquinone (coenzyme Q) biosynthetic pathway. This assignment is codified by HAMAP-Rule MF_01636 (which defines the UbiD family) and by the enzyme classification EC 4.1.1.98. The reaction was directly characterized in orthologs from E. coli and P. aeruginosa, and PP_5213 is the canonical single-copy ubiD ortholog in P. putida KT2440.
The mechanistic role is stated explicitly in the literature: "The 3-polyprenyl-4-hydroxybenzoate decarboxylase (UbiD) catalyzes the conversion of 3-polyprenyl-4-hydroxybenzoate to 2-polyprenylphenol in the biosynthesis of ubiquinone" PMID: 23671667. A second study confirms the specific ubiquinone context: "ubiX and ubiD, which are responsible for decarboxylation of the 3-octaprenyl-4-hydroxybenzoate precursor" PMID: 26083743. Loss-of-function studies of the pathway reinforce this: an E. coli strain defective in the UbiX/UbiD decarboxylation step "accumulates 4-hydroxy-3-octaprenyl-benzoate" and produces very low levels of Q PMID: 17889824, pinpointing the decarboxylation step catalyzed by UbiD as the metabolic bottleneck.
UbiD is catalytically inactive as an apoprotein. It requires prenylated FMN (prFMN), a modified flavin bearing a fourth non-aromatic ring formed by covalently linking a dimethylallyl moiety to the FMN N5 and C6 atoms. This cofactor is synthesized by the partner enzyme UbiX, a flavin prenyltransferase that transfers the dimethylallyl group from dimethylallyl-monophosphate (DMAP) or dimethylallyl-pyrophosphate (DMAPP) to FMN.
The discovery paper establishes both the enzymatic source and chemical structure of the cofactor: "UbiX produces a novel flavin-derived cofactor required for the decarboxylase activity of UbiD. UbiX acts as a flavin prenyltransferase, linking a dimethylallyl moiety to the flavin N5 and C6 atoms. This adds a fourth non-aromatic ring to the flavin isoalloxazine group" PMID: 26083743. After prenylation, the cofactor must undergo an activation step: "Following prenylation, prFMN undergoes oxidative maturation to form the iminium species required for UbiD activity" PMID: 32951834. The same modified cofactor was shown to be shared between the ubiquinone pathway (UbiX/UbiD) and the aromatic-acid decarboxylases (PAD1/FDC), and endogenous UbiX can activate FDC — implying "the same cofactor is required for decarboxylation of 4-hydroxy-3-polyprenylbenzoic acid by UbiD" PMID: 25647642.
Atomic-resolution crystal structures of the UbiD-family model enzyme Fdc1 show that oxidized prFMN adopts azomethine ylide (1,3-dipole) character. Substrate binding positions the reactive (dipolarophile) group directly above this ylide, enabling a 1,3-dipolar cycloaddition that underpins the reversible (de)carboxylation chemistry. This was proposed as the first known enzymatic example of such a reaction: "we propose that this presents the first example, to our knowledge, of an enzymatic 1,3-dipolar cycloaddition reaction" PMID: 26083754. The structural basis is described directly: "Substrate binding positions the dipolarophile enoic acid group directly above the azomethine ylide group" PMID: 26083754.
It is worth noting that the precise mechanism may vary across the family — for example, quantum-chemical work on the UbiD-family enzyme HmfF (furandicarboxylic acid decarboxylase) proposes a nucleophilic attack rather than a concerted cycloaddition PMID: 40343387 — but the cycloaddition model is the canonical mechanism for prFMN-dependent (de)carboxylation.
Rather than being a strictly membrane-embedded process, the terminal reactions of ubiquinone biosynthesis are carried out by a soluble, cytoplasmic multienzyme complex. In E. coli, "seven Ubi proteins form the Ubi complex, a stable metabolon that catalyzes the last six reactions of the UQ biosynthetic pathway" PMID: 30686758. Critically, the complex was purified from the cytosol and shown to be functional there: "We purify the Ubi complex from cytoplasmic extracts and demonstrate that UQ biosynthesis occurs in this fraction, challenging the current thinking of a membrane-associated biosynthetic process" PMID: 30686758. The hydrophobic polyprenyl-tailed intermediates are chaperoned within the complex by the SCP2 lipid-binding domain of UbiJ, allowing water-soluble handling of otherwise membrane-partitioning substrates PMID: 36142227. This locates the UbiD reaction on the cytoplasmic side of the cell, within a soluble metabolon, even though the final product (ubiquinone) resides in the membrane.
Crystal structures of UbiD-family members — including P. aeruginosa PA0254 and E. coli UbiD — reveal a conserved three-domain subunit: "an N-terminal α/β domain, a split β-barrel with a similar fold of a family of flavin reductases and a C-terminal α/β domain with a topology characteristic for the UbiD protein family" PMID: 23671667. The central split β-barrel is the flavin/prFMN-binding module (a flavin-reductase-like fold), and the C-terminal domain is diagnostic of the family. The family is functionally diverse: "considerable variation exists in the many branches of the UbiD family tree" PMID: 28754323. The canonical ubiquinone-pathway UbiD (to which Q88CG8 belongs) is distinct from other branches catalyzing (de)carboxylation of ferulate, phenazine-1-carboxylate, furandicarboxylate, and other aromatic/unsaturated acids used in lignin and aromatic-compound biotransformation.
UniProt curation of Q88CG8 provides the following organism-specific annotations, consistent with the family: Function — "Catalyzes the decarboxylation of 3-octaprenyl-4-hydroxy benzoate to 2-octaprenylphenol, an intermediate step in ubiquinone biosynthesis"; Cofactor — "Binds 1 prenylated FMN per subunit"; Subunit — "Homohexamer"; an annotated Active Site functioning as a "Proton donor"; and family assignment to UbiD. The catalyzed reaction is mapped to RHEA:41680 (3-octaprenyl-4-hydroxybenzoate = 2-octaprenylphenol + CO₂), EC 4.1.1.98.
UbiD-family enzymes catalyze reversible (de)carboxylation of aromatic and aliphatic/acrylic substrates via prFMN. The reverse (carboxylation) direction is physiologically relevant: "It has been proposed that the first step in anaerobic microbial degradation of recalcitrant aromatic compounds is a UbiD-mediated carboxylation" PMID: 32719558, and these enzymes are exploited for enzymatic C–H carboxylation. The family is enormous — "There are now ∼35 000 protein sequences annotated as hypothetical UbiD-like enzymes" PMID: 38837123 — spanning dozens of decarboxylase subfamilies. Substrate handling differs by chemistry: turnover of bulky aromatic substrates requires prFMN-binding-domain motion, since "during aromatic acid decarboxylation, substantial rearrangement of the substrate aromatic moiety associated with covalent catalysis presents a molecular dynamic challenge" PMID: 34417452, whereas smaller acrylic substrates react within a closed active site. This domain dynamics is directly relevant to UbiD, whose physiological substrate carries a very bulky polyprenyl-hydroxybenzoate moiety.
UniProt curated keywords for Q88CG8 place its subcellular location at the Cell membrane — specifically, HAMAP-Rule MF_01636 annotates UbiD as a peripheral membrane protein on the cytoplasmic side. Additional keywords include Manganese, Metal-binding, FMN, Decarboxylase, and Ubiquinone biosynthesis. Structurally, the P. aeruginosa PA0254 UbiD structure shows a conserved divalent-metal site (Mg²⁺, ligated by invariant His and Glu residues) adjacent to the active-site cleft PMID: 23671667. This peripheral, cytoplasmic-side localization is fully consistent with the finding that UQ biosynthesis (including UbiD) is executed by a soluble cytoplasmic Ubi metabolon PMID: 30686758.
A UniProt query of P. putida KT2440 (taxon 160488) returns Q88QE6 "Flavin prenyltransferase UbiX", the partner enzyme that synthesizes prFMN. Because UbiD (Q88CG8) is catalytically inert without prFMN, the presence of a cognate UbiX in the same genome establishes a complete, functional UbiX–UbiD prFMN-dependent decarboxylation module in P. putida. This mirrors the tightly linked UbiX/UbiD systems characterized in E. coli and yeast PMID: 25647642; PMID: 26083743.
Chemotaxonomic data show that ubiquinone-9 (Q-9) is the characteristic respiratory quinone of Pseudomonas and its close relatives. For a Pseudomonadales isolate whose closest cultivated neighbor is Pseudomonas putida R43, "The only respiratory quinone detected was ubiquinone-9 (Q-9)" PMID: 27054961. Therefore, although the enzyme name and annotation use "octaprenyl" (inherited from E. coli, which makes Q-8), the physiological substrate and product in P. putida bear a C45 nonaprenyl (9-isoprene) tail. The reaction in this organism is precisely: decarboxylation of 3-nonaprenyl-4-hydroxybenzoate → 2-nonaprenylphenol + CO₂. The enzyme's catalytic chemistry is identical; only the chain length of the isoprenoid tail differs.
UbiD occupies a single, well-defined position in the bacterial ubiquinone (coenzyme Q) biosynthetic pathway: it removes the carboxyl group from the aromatic ring of the polyprenylated 4-hydroxybenzoate intermediate. The following diagram places UbiD in its pathway context (chain length shown for P. putida, which makes Q-9):
4-hydroxybenzoate (4-HB)
|
| UbiA (polyprenyltransferase; attaches C45 nonaprenyl tail)
v
3-nonaprenyl-4-hydroxybenzoate ────────────────┐
| │ prFMN cofactor
| UbiD (Q88CG8, PP_5213) │ supplied by
| EC 4.1.1.98 │ UbiX (Q88QE6)
| requires prFMN (1 per subunit) │ via FMN + DMAP/DMAPP
v │
2-nonaprenylphenol + CO2 <────────────────────┘
|
| UbiG, UbiH, UbiE, UbiF ... (ring hydroxylations/methylations)
v
Ubiquinone-9 (Coenzyme Q9) → inserted into inner membrane
→ respiratory electron transport
Cofactor logic. The unusual chemistry of a non-oxidative decarboxylation on an aromatic ring is made possible by prFMN. UbiX first builds prFMN by prenylating FMN (adding a fourth ring across N5–C6); oxidative maturation then generates the iminium/azomethine-ylide species. In the mature cofactor, the ylide behaves as a 1,3-dipole. The substrate's reactive group docks over the ylide, and a reversible 1,3-dipolar cycloaddition forms a covalent substrate–cofactor adduct; CO₂ is then eliminated and the product released. Because the cycloaddition is reversible, UbiD-family enzymes can run in either the decarboxylation or carboxylation direction depending on conditions — the basis for both their physiological reverse-direction roles in anaerobic aromatic degradation and their biocatalytic exploitation.
Spatial logic. Although the end product ubiquinone is a membrane lipid and UbiD is annotated as a peripheral membrane protein on the cytoplasmic side, the enzyme physically works within a soluble cytoplasmic metabolon. This resolves an apparent paradox: the substrate is extremely hydrophobic (a C45 isoprenoid tail), yet the reaction runs in the aqueous cytosol. The metabolon's UbiJ SCP2 lipid-binding domain sequesters the hydrophobic tail, presenting the reactive aromatic head group to the successive Ubi enzymes — including UbiD — in an assembly-line fashion. UbiD's own bulky substrate additionally demands prFMN-domain motion, consistent with the "molecular dynamic challenge" observed for aromatic decarboxylation across the family.
The table below summarizes the enzyme's key properties as they apply to Q88CG8:
| Property | Value | Basis |
|---|---|---|
| Gene / locus | ubiD / PP_5213 | UniProt Q88CG8 |
| Enzyme name | 3-octaprenyl-4-hydroxybenzoate carboxy-lyase | UniProt / HAMAP MF_01636 |
| EC number | 4.1.1.98 | UniProt / HAMAP |
| Reaction (RHEA) | 3-octaprenyl-4-hydroxybenzoate → 2-octaprenylphenol + CO₂ (RHEA:41680) | UniProt |
| Physiological substrate in P. putida | 3-nonaprenyl-4-hydroxybenzoate (Q-9 organism) | PMID: 27054961 |
| Cofactor | 1 prenylated FMN (prFMN) per subunit | UniProt; PMID: 26083743 |
| Cofactor supplier | UbiX (Q88QE6 in KT2440) | UniProt; PMID: 26083743 |
| Mechanism | Reversible 1,3-dipolar cycloaddition | PMID: 26083754 |
| Metal | Divalent metal (Mn/Mg), His/Glu-ligated | UniProt; PMID: 23671667 |
| Oligomeric state | Homohexamer | UniProt |
| Domain architecture | N-terminal α/β + central split β-barrel + C-terminal α/β | PMID: 23671667 |
| Localization | Peripheral membrane protein, cytoplasmic side; functions in soluble Ubi metabolon | UniProt; PMID: 30686758 |
| Pathway | Ubiquinone (coenzyme Q) biosynthesis | Multiple |
| PMID | Title (abbreviated) | How it supports the annotation |
|---|---|---|
| 23671667 | Structural insights into the UbiD family from PA0254 (P. aeruginosa) | Direct structure of a Pseudomonas UbiD ortholog; defines the three-domain fold, the reaction (3-polyprenyl-4-HB → 2-polyprenylphenol), and the conserved divalent-metal site. Strongest structural evidence for the family in the target genus. |
| 26083743 | UbiX is a flavin prenyltransferase required for bacterial ubiquinone biosynthesis | Establishes prFMN as the UbiX-made cofactor required for UbiD activity, its chemical structure, and the UbiX/UbiD role in decarboxylating the octaprenyl-4-hydroxybenzoate precursor. |
| 26083754 | New cofactor supports unsaturated acid decarboxylation via 1,3-dipolar cycloaddition | Provides the catalytic mechanism (azomethine ylide / 1,3-dipolar cycloaddition) and the structural basis for reversible (de)carboxylation. |
| 32951834 | Biochemistry of prenylated-FMN enzymes | Confirms oxidative maturation of prFMN to the active iminium species required by UbiD. |
| 25647642 | Isofunctional PAD1 and UbiX catalyze formation of a novel cofactor | Shows the same modified-FMN cofactor is shared by UbiD (ubiquinone) and FDC (aromatic acids); links UbiX activity to 4-hydroxy-3-polyprenylbenzoate decarboxylation. |
| 17889824 | Role of UbiX in E. coli coenzyme Q biosynthesis | Genetic loss-of-function: disrupting the UbiX/UbiD decarboxylation step causes accumulation of 4-hydroxy-3-octaprenyl-benzoate and low Q, localizing UbiD's step in the pathway. |
| 30686758 | A Soluble Metabolon Synthesizes the Isoprenoid Lipid Ubiquinone | Demonstrates that UQ biosynthesis (including UbiD) occurs in a soluble cytoplasmic ~1-MDa metabolon, defining the enzyme's operational localization. |
| 36142227 | Functional role of UbiJ-UbiK | Explains how the SCP2 domain of UbiJ solubilizes hydrophobic UQ intermediates within the cytosolic complex. |
| 28754323 | The UbiX-UbiD system | Reviews family diversity; distinguishes the ubiquinone branch from aromatic-acid decarboxylase branches. |
| 34417452 | UbiD domain dynamics underpins aromatic decarboxylation | Shows bulky aromatic substrates require prFMN-domain motion — relevant to UbiD's large polyprenyl substrate. |
| 32719558 | Enzymatic C-H activation through CO2 fixation | Documents reversibility and the physiologically relevant carboxylation direction. |
| 38837123 | Surveying aromatic decarboxylations by prFMN enzymes | Quantifies the ~35,000-sequence breadth of the UbiD family and its substrate diversity. |
| 27054961 | Ventosimonas gracilis (Pseudomonadales) | Chemotaxonomic evidence that Q-9 is the respiratory quinone of Pseudomonas relatives, fixing the isoprenoid chain length of the UbiD substrate in P. putida. |
| 40343387 | QM study of furandicarboxylic acid decarboxylase (HmfF) | Cautionary note: some UbiD-family members may use nucleophilic-attack rather than concerted cycloaddition mechanisms. |
Identity verification. All mandatory verification checks pass. The gene symbol ubiD matches the protein description (3-octaprenyl-4-hydroxybenzoate carboxy-lyase); the organism is P. putida KT2440; the UbiD-family domains (IPR002830, IPR023677, etc.) align with the three-domain architecture reported in structural literature; and no conflicting literature for a different gene with the same symbol was encountered. The assignment is unambiguous.
No enzyme-specific biochemistry for Q88CG8 itself. The functional assignment for P. putida PP_5213 rests on (a) UniProt/HAMAP curation and (b) direct characterization of orthologs (E. coli UbiD, P. aeruginosa PA0254, and the model enzyme Fdc1). No purified-enzyme kinetics (kcat, Km), crystal structure, or gene-knockout phenotype has been reported specifically for the KT2440 protein. The inference is strong by homology but not directly demonstrated.
Substrate chain length inferred, not measured. The conclusion that the physiological substrate carries a nonaprenyl (Q-9) tail is inferred from Pseudomonas chemotaxonomy rather than from a direct assay of the KT2440 enzyme with defined-chain substrates. UbiD is known to be relatively permissive about tail length, so this is a well-supported inference but remains indirect.
Mechanistic universality. The 1,3-dipolar cycloaddition model derives chiefly from Fdc1 and related aromatic-acid decarboxylases. At least one computational study (HmfF) argues for an alternative nucleophilic mechanism, so the exact microscopic mechanism for the polyprenyl-hydroxybenzoate substrate has not been experimentally resolved for UbiD.
Metal identity. UniProt keywords list both Manganese and generic metal-binding, while the PA0254 structure modeled Mg²⁺. The physiologically relevant divalent metal for the P. putida enzyme is not firmly established.
Metabolon composition in Pseudomonas. The soluble Ubi metabolon was characterized in E. coli. Whether P. putida assembles an identical complex (including UbiJ/UbiK orthologs and the same stoichiometry) has not been directly shown, though the pathway is conserved.
Direct biochemical characterization of PP_5213. Heterologously express and purify Q88CG8 (co-expressing UbiX Q88QE6 to load prFMN, or reconstituting with purified prFMN), then measure decarboxylation of synthetic 3-prenyl-4-hydroxybenzoate analogs of varying chain length to confirm activity and probe chain-length preference (nonaprenyl vs. octaprenyl vs. short-chain surrogates).
Genetic complementation / knockout. Delete ubiD (PP_5213) in KT2440 and test for (a) loss of Q-9, (b) accumulation of 3-nonaprenyl-4-hydroxybenzoate, and (c) a respiratory/succinate growth defect; complement with the wild-type gene to confirm causality — mirroring the E. coli UbiX study PMID: 17889824.
Structure determination. Solve the crystal or cryo-EM structure of the KT2440 UbiD homohexamer with bound prFMN (and, ideally, a substrate/inhibitor) to confirm the divalent-metal identity, the proton-donor active-site residue, and the domain-dynamics required for the bulky polyprenyl substrate.
Metabolon reconstitution. Test whether P. putida forms a soluble Ubi metabolon by co-purification/pull-down of UbiD with UbiJ/UbiK/UbiH/UbiG orthologs from cytoplasmic extracts, quantifying UQ synthesis in the soluble fraction as done for E. coli PMID: 30686758.
Reverse-reaction / biocatalysis assessment. Given the family's reversible chemistry and biotechnological interest, test whether the KT2440 enzyme can catalyze carboxylation of 2-prenylphenol analogs under CO₂-rich conditions, informing potential use in enzymatic C–H carboxylation PMID: 32719558.
Report compiled from 5 iterations of autonomous investigation; 10 confirmed findings; 27 papers reviewed. All functional claims are anchored to UniProt curation of Q88CG8 and to primary/structural literature on directly characterized UbiD-family orthologs.